Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Zuyang Yuan"'
Autor:
Mary L. Stackpole, Weihua Zeng, Shuo Li, Chun-Chi Liu, Yonggang Zhou, Shanshan He, Angela Yeh, Ziye Wang, Fengzhu Sun, Qingjiao Li, Zuyang Yuan, Asli Yildirim, Pin-Jung Chen, Paul Winograd, Benjamin Tran, Yi-Te Lee, Paul Shize Li, Zorawar Noor, Megumi Yokomizo, Preeti Ahuja, Yazhen Zhu, Hsian-Rong Tseng, James S. Tomlinson, Edward Garon, Samuel French, Clara E. Magyar, Sarah Dry, Clara Lajonchere, Daniel Geschwind, Gina Choi, Sammy Saab, Frank Alber, Wing Hung Wong, Steven M. Dubinett, Denise R. Aberle, Vatche Agopian, Steven-Huy B. Han, Xiaohui Ni, Wenyuan Li, Xianghong Jasmine Zhou
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/099e0ea22a6b40a8ad77bcf1133b06ef
Autor:
Mary L. Stackpole, Weihua Zeng, Shuo Li, Chun-Chi Liu, Yonggang Zhou, Shanshan He, Angela Yeh, Ziye Wang, Fengzhu Sun, Qingjiao Li, Zuyang Yuan, Asli Yildirim, Pin-Jung Chen, Paul Winograd, Benjamin Tran, Yi-Te Lee, Paul Shize Li, Zorawar Noor, Megumi Yokomizo, Preeti Ahuja, Yazhen Zhu, Hsian-Rong Tseng, James S. Tomlinson, Edward Garon, Samuel French, Clara E. Magyar, Sarah Dry, Clara Lajonchere, Daniel Geschwind, Gina Choi, Sammy Saab, Frank Alber, Wing Hung Wong, Steven M. Dubinett, Denise R. Aberle, Vatche Agopian, Steven-Huy B. Han, Xiaohui Ni, Wenyuan Li, Xianghong Jasmine Zhou
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-12 (2022)
Abstract Early cancer detection by cell-free DNA faces multiple challenges: low fraction of tumor cell-free DNA, molecular heterogeneity of cancer, and sample sizes that are not sufficient to reflect diverse patient populations. Here, we develop a ca
Externí odkaz:
https://doaj.org/article/20fb32eadefd4ac09f8fb1699d2139b7
Autor:
Shuo Li, Zorawar S. Noor, Weihua Zeng, Mary L. Stackpole, Xiaohui Ni, Yonggang Zhou, Zuyang Yuan, Wing Hung Wong, Vatche G. Agopian, Steven M. Dubinett, Frank Alber, Wenyuan Li, Edward B. Garon, Xianghong Jasmine Zhou
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
It is possible to call single-nucleotide variant (SNV) in cell-free DNA (cfDNA), but the accuracy of detection is often affected by low tumour cfDNA content. Here, the authors develop a method, cfSNV, and show that it can be used even for medium-cove
Externí odkaz:
https://doaj.org/article/b75641b56a1844ef8994d8abd02e0b66
Autor:
Xianghong Jasmine Zhou, Wenyuan Li, Steven M. Dubinett, Edward B. Garon, Sanaz Memarzadeh, Adam Neal, Zuyang Yuan, Zorawar S. Noor, Mary L. Stackpole, Yonggang Zhou, Xiaohui Ni, Weihua Zeng, Shuo Li
Supplementary Figure from cfTrack: A Method of Exome-Wide Mutation Analysis of Cell-free DNA to Simultaneously Monitor the Full Spectrum of Cancer Treatment Outcomes Including MRD, Recurrence, and Evolution
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d146f5d8a1084128d29ddeae486e8cb
https://doi.org/10.1158/1078-0432.22484417.v1
https://doi.org/10.1158/1078-0432.22484417.v1
Autor:
Xianghong Jasmine Zhou, Wenyuan Li, Steven M. Dubinett, Edward B. Garon, Sanaz Memarzadeh, Adam Neal, Zuyang Yuan, Zorawar S. Noor, Mary L. Stackpole, Yonggang Zhou, Xiaohui Ni, Weihua Zeng, Shuo Li
Purpose:Cell-free DNA (cfDNA) offers a noninvasive approach to monitor cancer. Here we develop a method using whole-exome sequencing (WES) of cfDNA for simultaneously monitoring the full spectrum of cancer treatment outcomes, including minimal residu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a7d09a4cbc6093f873b9ed00bd219ac
https://doi.org/10.1158/1078-0432.c.6531398
https://doi.org/10.1158/1078-0432.c.6531398
Autor:
Xianghong Jasmine Zhou, Wenyuan Li, Steven M. Dubinett, Edward B. Garon, Sanaz Memarzadeh, Adam Neal, Zuyang Yuan, Zorawar S. Noor, Mary L. Stackpole, Yonggang Zhou, Xiaohui Ni, Weihua Zeng, Shuo Li
Supplementary Table from cfTrack: A Method of Exome-Wide Mutation Analysis of Cell-free DNA to Simultaneously Monitor the Full Spectrum of Cancer Treatment Outcomes Including MRD, Recurrence, and Evolution
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59403ad6df4194b78e72c6f7ac0f4167
https://doi.org/10.1158/1078-0432.22484399
https://doi.org/10.1158/1078-0432.22484399
Autor:
Shuo Li, Weihua Zeng, Xiaohui Ni, Yonggang Zhou, Mary L. Stackpole, Zorawar S. Noor, Zuyang Yuan, Adam Neal, Sanaz Memarzadeh, Edward B. Garon, Steven M. Dubinett, Wenyuan Li, Xianghong Jasmine Zhou
Publikováno v:
Clin Cancer Res
Purpose:Cell-free DNA (cfDNA) offers a noninvasive approach to monitor cancer. Here we develop a method using whole-exome sequencing (WES) of cfDNA for simultaneously monitoring the full spectrum of cancer treatment outcomes, including minimal residu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45a0a86e4f8bfffe85d2320c2bb99679
https://doi.org/10.1158/1078-0432.ccr-21-1242
https://doi.org/10.1158/1078-0432.ccr-21-1242
Autor:
Yin Li, Xiao Geng, Juwei Mu, Shugeng Gao, Zuyang Yuan, Jie He, Fengwei Tan, Xinfeng Wang, Qi Xue
Publikováno v:
Cancer Communications
Esophageal cancer (EC) is a common cancer and is histopathologically classified into esophageal squamous cell carcinoma and esophageal adenocarcinoma. EC is a worldwide public health issue because of late diagnosis and lack of effective therapy. In c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f7c1fb8e6048e8e395141415c36f1c6
https://doi.org/10.1002/cac2.12118
https://doi.org/10.1002/cac2.12118
Autor:
Wei Cui, Fengwei Tan, Feng Chen, Shuangshuang Mao, Nan Sun, Yan Chen, Yun Che, Guangli Shi, Shouguo Sun, Jun Qi, Ning Li, Yuanyuan Lei, Jinling Wang, Jianbing Huang, Yibo Gao, Ruochuan Zang, Yuan Li, Jie He, Zuyang Yuan, Zhiliang Lu, Jia Gao, Rong Min
Publikováno v:
Cancer Science
We aimed to verify the expression status and diagnostic significance of isocitrate dehydrogenase 1 (IDH1) in non‐small‐cell lung cancer (NSCLC), especially during early stages. Serum IDH1 levels were measured by ELISA. A total of 1223 participant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6889348ebd20f5de873976e8dcdd10b8
http://europepmc.org/articles/PMC7226212
http://europepmc.org/articles/PMC7226212
Autor:
Edward B. Garon, Shuo Li, Adam Neal, Xiaohui Ni, Xianghong Jasmine Zhou, Weihua Zeng, Sanaz Memarzadeh, Zorawar S. Noor, Steven M. Dubinett, Wenyuan Li, Yonggang Zhou, Mary L. Stackpole, Zuyang Yuan
PurposeCell-free DNA (cfDNA) offers a non-invasive approach to monitor cancer. Here we develop a method using whole-exome sequencing (WES) of cfDNA for simultaneously monitoring the full spectrum of cancer treatment outcomes, including MRD, recurrenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c7f907ecf402bc606e3f243d2030a09
https://doi.org/10.1101/2021.11.07.21265999
https://doi.org/10.1101/2021.11.07.21265999